AHA advocates for stronger health care supply chain in comments for House subcommittee hearing

Jun 11, 2025 - 03:20 PM
US Capitol with flag 900 x 400

The AHA submitted a statement today to the House Energy and Commerce Subcommittee on Health for a hearing today on the health care supply chain. The AHA advocated for strengthening the health care supply chain while acknowledging significant time would be needed due to logistical complexities and resources needed to do so. 
 
Additionally, the AHA noted that pharmaceuticals sourced from overseas are significantly important for patients, such as cancer and cardiovascular medications, immunosuppressives, antibiotics and combination antibiotics. The AHA also reiterated its support for the Mapping America’s Pharmaceutical Supply Act (S. 1784), legislation that would require the Department of Health and Human Services to perform a comprehensive risk assessment of the entire U.S. pharmaceutical supply chain. 

Related News Articles

Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
ASPR launches competition on improving domestic production of critical medical supplies
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
USTR proposes additional tariffs on certain nations, citing failure to impose or enforce ban on forced labor
The U.S. Trade Representative yesterday announced plans to impose additional tariffs on goods from certain nations that it said had lacked or failed…
Headline
FDA announces shortage of products used for neurosurgery, microsurgery expected to continue remainder of 2026
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to…
Headline
HSCC releases guide on third-party AI risk, supply chain transparency
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
Administration announces additional pharmaceutical tariffs
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…